Canadian Journal of Kidney Health and Disease (Aug 2021)

Impact of Perioperative Complications on Living Kidney Donor Health-Related Quality of Life and Mental Health: Results From a Prospective Cohort Study

  • Carlos Garcia-Ochoa,
  • Liane S. Feldman,
  • Chris Nguan,
  • Mauricio Monroy-Caudros,
  • Jennifer B. Arnold,
  • Lianne Barnieh,
  • Neil Boudville,
  • Meaghan S. Cuerden,
  • Christine Dipchand,
  • John S. Gill,
  • Martin Karpinski,
  • Scott Klarenbach,
  • Greg Knoll,
  • Charmaine E. Lok,
  • Matthew Miller,
  • G. V. Ramesh Prasad,
  • Jessica M. Sontrop,
  • Leroy Storsley,
  • Amit X. Garg

DOI
https://doi.org/10.1177/20543581211037429
Journal volume & issue
Vol. 8

Abstract

Read online

Background: Although living kidney donation is safe, some donors experience perioperative complications. Objective: This study explored how perioperative complications affected donor-reported health-related quality of life, depression, and anxiety. Design: This research was a conducted as a prospective cohort study. Setting: Twelve transplant centers across Canada. Patients: A total of 912 living kidney donors were included in this study. Measurements: Short Form 36 health survey, Beck Depression Inventory and Beck Anxiety Inventory. Methods: Living kidney donors were prospectively enrolled predonation between 2009 to 2014. Donor perioperative complications were graded using the Clavien-Dindo classification system. Mental and physical health-related quality of life was assessed with the 3 measurements; measurements were taken predonation and at 3- and 12-months postdonation. Results: Seventy-four donors (8%) experienced a perioperative complication; most were minor (n = 67 [91%]), and all minor complications resolved before hospital discharge. The presence (versus absence) of a perioperative complication was associated with lower mental health-related quality of life and higher depression symptoms 3-month postdonation; neither of these differences persisted at 12-month. Perioperative complications were not associated with any changes in physical health-related quality of life or anxiety 3-month postdonation. Limitations: Minor complications may have been missed and information on complications postdischarge were not collected. No minimal clinically significant change has been defined for kidney donors across the 3 measurements. Conclusions: These findings highlight a potential opportunity to better support the psychosocial needs of donors who experience perioperative complications in the months following donation. Trial registration: NCT00319579 and NCT00936078.